US6596284B1ExpiredUtility
Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
Priority: Apr 30, 2002Filed: Apr 30, 2002Granted: Jul 22, 2003
Est. expiryApr 30, 2022(expired)· nominal 20-yr term from priority
A61K 31/352A61K 31/4741A61K 47/02A61K 31/277A61K 9/0014
81
PatentIndex Score
20
Cited by
17
References
4
Claims
Abstract
The present invention relates to the prevention and treatment of atopic dermatitis and treatment of atopic dermatitis and other eczematous disorders by application of topical mast cell stabilizers including cromolyn sodium, nedocromil or lodoxamide, in a vehicle of a buffered isotonic saline solution (OCEAN®).
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A topical preparation suitable for application as spray or drops, said preparation comprising an effective amount of a topical mast cell stabilizer to inhibit release of mast cell mediators, and said topical mast cell stabilizer selected from the group consisting of cromolyn sodium, nedocromil and lodoxamide, and an isotonic solution containing 0.65% sodium chloride in water with phenylcarbinol and benzalkonium chloride.
2. The preparation of claim 1 , wherein the effective amount of cromolyn sodium in the range of a concentration of 0.5% to 5.0%.
3. The preparation of claim 1 , wherein the effective amount of nedocromil is in the range of a concentration of 0.1% to 8.0%.
4. The preparation of claim 1 , wherein the effective amount of lodoxamide is in the range of a concentration of 0.1% to 10%.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.